These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 27569995

  • 1. Antidepressant-like effects of scopolamine in mice are enhanced by the group II mGlu receptor antagonist LY341495.
    Podkowa K, Podkowa A, Sałat K, Lenda T, Pilc A, Pałucha-Poniewiera A.
    Neuropharmacology; 2016 Dec; 111():169-179. PubMed ID: 27569995
    [Abstract] [Full Text] [Related]

  • 2. Role of AMPA receptor stimulation and TrkB signaling in the antidepressant-like effect of ketamine co-administered with a group II mGlu receptor antagonist, LY341495, in the forced swim test in rats.
    Pałucha-Poniewiera A, Podkowa K, Pilc A.
    Behav Pharmacol; 2019 Sep; 30(6):471-477. PubMed ID: 30724804
    [Abstract] [Full Text] [Related]

  • 3. The Antidepressant Effects of an mGlu2/3 Receptor Antagonist and Ketamine Require AMPA Receptor Stimulation in the mPFC and Subsequent Activation of the 5-HT Neurons in the DRN.
    Fukumoto K, Iijima M, Chaki S.
    Neuropsychopharmacology; 2016 Mar; 41(4):1046-56. PubMed ID: 26245499
    [Abstract] [Full Text] [Related]

  • 4. The group II mGlu receptor antagonist LY341495 induces a rapid antidepressant-like effect and enhances the effect of ketamine in the chronic unpredictable mild stress model of depression in C57BL/6J mice.
    Pałucha-Poniewiera A, Podkowa K, Rafało-Ulińska A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jul 13; 109():110239. PubMed ID: 33400944
    [Abstract] [Full Text] [Related]

  • 5. Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats.
    Podkowa K, Pochwat B, Brański P, Pilc A, Pałucha-Poniewiera A.
    Psychopharmacology (Berl); 2016 Aug 13; 233(15-16):2901-14. PubMed ID: 27286960
    [Abstract] [Full Text] [Related]

  • 6. The potential antidepressant action and adverse effects profile of scopolamine co-administered with the mGlu7 receptor allosteric agonist AMN082 in mice.
    Podkowa K, Pilc A, Podkowa A, Sałat K, Marciniak M, Pałucha-Poniewiera A.
    Neuropharmacology; 2018 Oct 13; 141():214-222. PubMed ID: 30145321
    [Abstract] [Full Text] [Related]

  • 7. The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood Circuits.
    Witkin JM, Monn JA, Schoepp DD, Li X, Overshiner C, Mitchell SN, Carter G, Johnson B, Rasmussen K, Rorick-Kehn LM.
    J Pharmacol Exp Ther; 2016 Jul 13; 358(1):71-82. PubMed ID: 27189960
    [Abstract] [Full Text] [Related]

  • 8. On the mechanism of the antidepressant-like action of group II mGlu receptor antagonist, MGS0039.
    Pałucha-Poniewiera A, Wierońska JM, Brański P, Stachowicz K, Chaki S, Pilc A.
    Psychopharmacology (Berl); 2010 Dec 13; 212(4):523-35. PubMed ID: 20703449
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression.
    Koike H, Fukumoto K, Iijima M, Chaki S.
    Behav Brain Res; 2013 Feb 01; 238():48-52. PubMed ID: 23098797
    [Abstract] [Full Text] [Related]

  • 14. The involvement of monoaminergic neurotransmission in the antidepressant-like action of scopolamine in the tail suspension test.
    Pałucha-Poniewiera A, Podkowa K, Lenda T, Pilc A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct 03; 79(Pt B):155-161. PubMed ID: 28647535
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. 5-HT1A receptor stimulation in the medial prefrontal cortex mediates the antidepressant effects of mGlu2/3 receptor antagonist in mice.
    Fukumoto K, Iijima M, Funakoshi T, Chaki S.
    Neuropharmacology; 2018 Jul 15; 137():96-103. PubMed ID: 29738849
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.